| Noncolorectal Gastrointestinal Cancer |
1 |
1 |
| Hepatocellular Carcinoma |
0 |
1 |
| Biologic Therapy |
0 |
0.86 |
| Cancer |
0 |
0.64 |
| Tumor |
0 |
0.56 |
| Cholangiocarcinoma |
0 |
0.99 |
| Immunocompromise |
0 |
0.24 |
| T-Lymphocyte |
0 |
0.11 |
| Healthcare and Medical Technology |
0 |
0.1 |
| Adenocarcinoma |
0 |
0.08 |
| Clinical Research |
0 |
0.08 |
| Fellowship |
0 |
0.08 |
| Immunotherapy |
0 |
0.08 |
| Lymphocytes |
0 |
0.08 |
| Minnesota |
0 |
0.08 |
| Natural Killer (NK) Cells |
0 |
0.08 |
| Receptors |
0 |
0.08 |
| Translational Research |
0 |
0.08 |